These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [The child and cancerous diseases (current general aspects of pediatric oncology)]. Goldiş G Rev Pediatr Obstet Ginecol Pediatr; 1982; 31(1):3-14. PubMed ID: 6808641 [No Abstract] [Full Text] [Related]
4. Age span challenges: adherence in pediatric oncology. Landier W Semin Oncol Nurs; 2011 May; 27(2):142-53. PubMed ID: 21514483 [TBL] [Abstract][Full Text] [Related]
5. Anesthetic considerations for the pediatric oncology patient--part 1: a review of antitumor therapy. Latham GJ; Greenberg RS Paediatr Anaesth; 2010 Apr; 20(4):295-304. PubMed ID: 20470332 [TBL] [Abstract][Full Text] [Related]
6. Interferon-alpha therapy in children with malignant diseases: clinical experience in twenty-four patients treated in a single pediatric oncology unit. Kiss C; Kiss M; Szegedi I; Arvai K; Tóth J; Oláh E Med Pediatr Oncol; 2002 Aug; 39(2):115-9. PubMed ID: 12116059 [No Abstract] [Full Text] [Related]
7. [Place of CSF in pediatric oncology]. Hartmann O; Valteau-Couanet D Pathol Biol (Paris); 1993 Jan; 41(1):52. PubMed ID: 7686289 [No Abstract] [Full Text] [Related]
8. [Chemotherapy of malignomas in childhood]. Haas H Z Allgemeinmed; 1975 Oct; 51(28):1247-8. PubMed ID: 1199148 [No Abstract] [Full Text] [Related]
9. Drug trials in pediatric oncology: a multi-facetted problem. Boos J Int J Clin Pharmacol Ther; 1998 Nov; 36(11):613-20. PubMed ID: 9849753 [TBL] [Abstract][Full Text] [Related]
10. A prospective study of the epidemiology of adverse drug reactions in pediatric hematology and oncology patients. Collins GE; Clay MM; Falletta JM Am J Hosp Pharm; 1974 Oct; 31(10):968-75. PubMed ID: 4440694 [No Abstract] [Full Text] [Related]
12. Creating an infrastructure for pediatric oncology drug development. Evans WE Clin Adv Hematol Oncol; 2007 Mar; 5(3):198-200. PubMed ID: 17519881 [No Abstract] [Full Text] [Related]
13. Complementary and alternative therapy use in pediatric oncology patients with failure of frontline chemotherapy. Paisley MA; Kang TI; Insogna IG; Rheingold SR Pediatr Blood Cancer; 2011 Jul; 56(7):1088-91. PubMed ID: 21360653 [TBL] [Abstract][Full Text] [Related]
14. American Academy of Pediatrics. Guidelines for the pediatric cancer center and role of such centers in diagnosis and treatment. Section on oncology-hematology. Pediatrics; 1986 Jun; 77(6):916-7. PubMed ID: 3714386 [No Abstract] [Full Text] [Related]
19. Regulatory approvals of pediatric oncology drugs: previous experience and new initiatives. Hirschfeld S; Ho PT; Smith M; Pazdur R J Clin Oncol; 2003 Mar; 21(6):1066-73. PubMed ID: 12637472 [TBL] [Abstract][Full Text] [Related]